Clinical trial Recruiting at 1 site Interventional Ages 18 to 99

Antrodia cinnamomea supplement to improve quality of life during chemotherapy for lung cancer

Official title: The Effects of Antrodia Cinnamomea Fruiting Body Extract on Quality of Life and Chemotherapy Side Effects in Patients With Lung Cancer Undergoing Platinum-Based Chemotherapy

Run by Tri-Service General Hospital (TSGH) · NCT07241182 · Data updated 2026-11-12

This trial will test whether taking a daily Antrodia cinnamomea-containing capsule helps people with lung cancer on platinum chemotherapy feel better by reducing nausea, improving sleep, and easing cancer-related symptoms.

More Lung Cancer (Diagnosis) trials

Quick facts

Study typeInterventional
Ages18 Years to 99 Years
SexAll
Enrollment40 (estimated)
SponsorTri-Service General Hospital (TSGH)
Academic / other
Drugs / interventionschemotherapy
Locations1 site (Taipei)
StatusRecruiting
StartedNovember 24, 2025
Main results expectedMarch 31, 2027
Study endsSeptember 30, 2027
Registry record updatedJanuary 8, 2026
Trial IDNCT07241182 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (age >18) with pathologically or radiographically confirmed lung cancer who are receiving platinum-based chemotherapy, have a life expectancy of at least six months, can take daily oral supplements, and meet laboratory and clinical safety requirements are ideal candidates.

Probably not a fit

Patients already taking Antrodia camphorata supplements, those with abnormal recent liver or kidney tests, active acute infections, major cardiac disease, severe neuropathy, known allergies to study ingredients, or those unable to comply with daily supplementation may not benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults with pathologically or radiographically confirmed lung cancer who are receiving platinum-based chemotherapy at Tri-Service General Hospital will be randomly assigned in a double-blind manner to receive either a capsule containing Antrodia cinnamomea plus turmeric and probiotics or a capsule with turmeric and probiotics only. Participants will take the assigned capsules daily for three months with continued follow-up for a total of six months (24 weeks). Researchers will use validated questionnaires to measure nausea and vomiting, sleep quality, overall quality of life, and other cancer-related symptoms and will compare outcomes between the two groups. The trial is conducted at Tri-Service General Hospital in Taipei and is sponsored by that hospital with collaboration from Balay Biotechnology Corporation.

Why it matters

Potential benefit: If successful, the supplement could reduce chemotherapy-related nausea, improve sleep, and meaningfully improve overall quality of life for patients receiving platinum-based chemotherapy for lung cancer.

How similar studies have gone: There are limited clinical data specifically on Antrodia cinnamomea for chemotherapy side effects; some preclinical and small human studies suggest potential benefits but robust randomized evidence is lacking.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Pathologically and radio-graphically diagnosed lung cancer
* Age greater than 18 years
* Received platinum-based chemotherapy
* Life expectancy of six months or longer

Exclusion Criteria:

* Inability to comply with timely supplementation administration.
* Within 14 days prior to trial entry, laboratory data showing abnormal liver function, abnormal kidney function
* Within 30 days prior to trial entry, unexplained fever ≥38.5°C for 7 consecutive days or chronic diarrhea for 15 consecutive days.
* Currently receiving hormone therapy.
* Major cardiac disease or arrhythmia severe enough that the attending physician considers the patient unsuitable for trial participation.
* Major neuropathy.
* Patients with currently active acute infections.
* Patients with known allergies/allergic reactions to the investigational product or any components in their formulations.
* Patients currently taking supplements containing Antrodia camphorata extract.

Where it's running

  • Tri-Service General Hospital
    Taipei, Taiwan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.